Answers are grounded in this paper and cite their sources.
Chronic kidney disease (CKD) is often associated with muscle wasting and impaired regeneration, but the underlying cellular mechanisms remain incompletely understood. To better understand how CKD compromises muscle regeneration, we investigated the effects of uremic toxins on muscle satellite cells (SCs), which are indispensable for myofiber formation. CKD was induced in mice by feeding them an adenine-containing diet. As expected, the CKD mice exhibited lower muscle mass and weaker grip strength than the control mice. Flow cytometry and immunohistochemistry revealed a significant decrease in the number of SCs in CKD mice. Conversely, the ratio of propidium iodide-positive SCs increased in CKD mice, indicating increased cell death. Muscle regeneration processes appeared normal after injury in CKD mice; however, muscle mass did not fully recover to baseline levels. Exposure of primary SCs to the uremic toxin indoxyl sulfate in vitro led to increased apoptosis and reduced cell viability. Notably, despite the reduced number of SCs, indoxyl sulfate did not obviously impair myotube formation in vitro, suggesting that SCs retain their myogenic capacity under CKD conditions. These findings suggest that uremic toxins primarily impair SC survival rather than differentiation, and that defective muscle regeneration is due, at least in part, to a reduced number of SCs in CKD mice. Our results suggest that maintaining the SC pool is crucial for preserving muscle regeneration capacity in CKD patients.
No takes yet. Share an insight, caveat, or question.
Sasaki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: